CPAN Advocacy Chat: Clinical Trials in the Community Setting

Advocacy Groups | <b>COA Patient Advocacy Network</b>

May 12, 2021

Clinical trials represent the forefront of our knowledge in cancer care. Patients participating in these trials are receiving the best of the best in cancer treatment – and advancing our ability to fight cancer in the future. The popular perception is that clinical trials are limited to university or hospital systems, but this couldn’t be further from the truth. At community oncology clinics around the nation, clinicians and patients are breaking ground in the fight against cancer with cutting edge clinical trials.

On May 12 at 12 p.m. ET, Katie Goodman, Vice President, Clinical Research, American Oncology Network (AON) and Rose Gerber, Director of Patient Advocacy & Education, COA, shared information from the provider and patient perspective on clinical trials, including understanding the different types of clinical trials, the rigorous safety review process, and who is eligible to take part in a trial (hint: just about anybody!). From contributing to advancements in care for patients to expanding one’s health outcomes, clinical trials provide opportunities for patients to make an impact on their own health care and on the lives of others going forward.

This event was part of our CPAN Advocacy Chats series – 30-minute, monthly educational webinars on key cancer issues and the policies that impact them. Each month features a new topic and special guests joining us. Patients, survivors, caregivers, and other cancer care advocates are all invited to join us for these free, interactive, virtual events!